• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2021 May 25;118(21):e2104547118.
doi: 10.1073/pnas.2104547118.
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities


Qing Yang[SUP] 1 2 [/SUP], Tassa K Saldi[SUP] 1 [/SUP], Patrick K Gonzales[SUP] 1 [/SUP], Erika Lasda[SUP] 1 [/SUP], Carolyn J Decker[SUP] 3 4 [/SUP], Kimngan L Tat[SUP] 1 [/SUP], Morgan R Fink[SUP] 1 [/SUP], Cole R Hager[SUP] 1 [/SUP], Jack C Davis[SUP] 1 [/SUP], Christopher D Ozeroff[SUP] 1 [/SUP], Denise Muhlrad[SUP] 3 4 [/SUP], Stephen K Clark[SUP] 1 5 [/SUP], Will T Fattor[SUP] 1 [/SUP], Nicholas R Meyerson[SUP] 1 5 [/SUP], Camille L Paige[SUP] 1 5 [/SUP], Alison R Gilchrist[SUP] 1 2 [/SUP], Arturo Barbachano-Guerrero[SUP] 1 [/SUP], Emma R Worden-Sapper[SUP] 1 2 [/SUP], Sharon S Wu[SUP] 1 2 6 [/SUP], Gloria R Brisson[SUP] 7 [/SUP], Matthew B McQueen[SUP] 8 [/SUP], Robin D Dowell[SUP] 1 2 9 [/SUP], Leslie Leinwand[SUP] 1 2 [/SUP], Roy Parker[SUP] 10 3 4 [/SUP], Sara L Sawyer[SUP] 10 2 [/SUP]



Affiliations

Abstract

We analyze data from the fall 2020 pandemic response efforts at the University of Colorado Boulder, where more than 72,500 saliva samples were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using qRT-PCR. All samples were collected from individuals who reported no symptoms associated with COVID-19 on the day of collection. From these, 1,405 positive cases were identified. The distribution of viral loads within these asymptomatic individuals was indistinguishable from what has been previously observed in symptomatic individuals. Regardless of symptomatic status, ?50% of individuals who test positive for SARS-CoV-2 seem to be in noninfectious phases of the disease, based on having low viral loads in a range from which live virus has rarely been isolated. We find that, at any given time, just 2% of individuals carry 90% of the virions circulating within communities, serving as viral "supercarriers" and possibly also superspreaders.

Keywords: SARS-CoV-2; transmission; viral load.
 
Back
Top Bottom